Ascend Wellness Holdings (AAWH) Net Cash Flow Growth (3y) (2023 - 2026)
Ascend Wellness Holdings (AAWH) Net Cash Flow Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 32.03% |
| 3 | Zoetis | 32.57 Bn | 30.63 Bn | 1.62 Bn | 28.99% |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn | 37.89% |
| 5 | United Therapeutics | 23.08 Bn | 20.93 Bn | 648.10 Mn | -49.94% |
| 6 | RedHill Biopharma | 22.43 Bn | 22.43 Bn | - | - |
| 7 | Viatris | 20.23 Bn | 18.42 Bn | 1.16 Bn | 37.74% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn | -41.05% |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | -62.71% |
| 10 | Ascend Wellness Holdings | 77.94 Mn | 17.02 Mn | 44.88 Mn | -207.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -207.67% |
| Dec 31, 2025 | 54.77% |
| Sep 30, 2025 | 45.41% |
| Jun 30, 2025 | -13.64% |
| Mar 31, 2025 | 44.36% |
| Dec 31, 2024 | 35.15% |
| Sep 30, 2024 | -29.74% |
| Jun 30, 2024 | -35.84% |
| Mar 31, 2024 | -57.56% |
| Dec 31, 2023 | -35.99% |
| Sep 30, 2023 | -96.10% |
| Jun 30, 2023 | -33.85% |
| Mar 31, 2023 | -109.83% |